close
close

Delivery card for PEGASYS® 135 ΜG: Would you rather use the medicine?

Delivery card for PEGASYS® 135 ΜG: Would you rather use the medicine?

The results in the year 2024 were reported by the Federal Institute for Medical Products and Medical Products (BfArM), which will continue with the PEGASYS® 135 ΜG Delivery Pass. If you have done some research and heard the Arzneimittel, check it out here on news.de!

Postage costs at Medikamenten it is possible to use a zunehmende herausforderung for general health in Germany. Let more patients work in a sensible way Medicines see if an alternative Treat the best, the benötigten Arzneimittel not verügbar bend. It may be that a person has a sum of money, other people may have the right to enjoy. The gold-plated effect on PEGASYS® 135 ΜG.

Production problem at PEGASYS® 135 ΜG

Aktuell is de Benachrichtigung über de Lieferengpass des Medikaments von farmant GmbH for the time period from 01.09.2024 to 30.06.2025 in Kraft. Since medicine plays an important role in the Krankenhäuser, this is not possible. As an alternative to PEGASYS® 135 ΜG, however, you are offered by the Federal Institute Hydroxyurea medac In the past, it was low and tense. This beach is here in Jedem Fall: products are only used after careful consideration.

The benefits of the medical management could be improved due to the different factors. These reichen von unreinigungen in de Arzneimitteln bis zur Einstellung der Produktion by Hersteller. Dennoch lies about the past of the problems, which for most Wirkstoffe now exists a novice Anzahl of Herstellern, of Danes who are in the Chinese states and where they often lie. I’m heading into the fall for post-BfArM drug time Production problem probably, we will offer as Detail “Herstellerwechsel”. Desweiteren therefore reinforces the Bundesinstitut: “pharma& expects that the production site of Loba biotech GmbH will be able to produce Pegasys® sometime in 2025, subject to collaborations and partnerships with regulatory authorities. Accordingly, we expect the limited availability of Pegasys® in various strength(s) on an ongoing basis worldwide, which will continue until additional product inventory is available for planned delivery, estimated sometime in 2025 and before June 30, 2025”.

PEGASYS® 135 ΜG: Die details for Arzneimittel

At PEGASYS® 135 ΜG it acts as a diversified Arzneimittel, das vor allem weg seines Wirkstoffes Peginterferon alfa-2a ((with Angabe der Molmasse des pegylierten Teils in x kDa)) of Bedeutung ist.
This care is taken into account when the following diagnosis is made:

  • Chronic viral hepatitis B without Delta Virus, Phase no longer available
  • There is no such thing as viral hepatitis or hepatic disease
  • Chronic Viral Hepatitis C
  • Chronic Viral Hepatitis B ohne Delta Virus
Medicine PEGASYS® 135 ΜG
Manufacturer zr pharma& GmbH – Zweigniederlassung Hietzing –
PZN 03352627
Active substance Peginterferon alfa-2a ((with Angabe der Molmasse des pegylierten Teils in x kDa))
Time course of poverty 01.09.2024 to 30.06.2025
relevant in the hospital no
Alternative preparation Hydroxyurea medac
Understanding for the Lieferengpass Manufacturer change

Also read:
Love pass for AGAKALIN® 100 MG: Darum ist the medication after which it is not available
Delivery pass for AGAKALIN® 80 MG: Who will hold the button for long?

Lieferengpässe in Deutschland aktuell – Ein Ende in Sicht?

The use of other English channels is unclear in the fall of PEGASYS® 135 ΜG, but it is clear that there is an end content of the geltungszeitraum.

The pharmacies are among other things ordered and must react with perhaps a wide view on the entprechenden Engpässe. In case of manchen Fallen it is wise to close the packaging size or to carry out alternatives. It is not that it no longer works in the big and the goose world, it is a long way to solving problems.
The cost of the expiry date of the charity pass of Arzneimitteln can best be considered as a certain time. From July 2023 in Kraft you will get “Regulation for the fight against love passes at Arzneimitteln and for the improvement of the supply” with the Ziel, the problem of the love passes einzudämmen. After the official website of the federal ministers was established, the production of medical products in Europe started, a re-examination of the charity pass and the offer of the Provider on high quality. It is not possible to solve the new rules if the problem occurs.

Follow you News.de clean at Facebook, Twitter, Pinterest and YouTubeHere you will find brandheiße News, active videos and the direct view of the editorial team.

+++ Editorial Hinweis: Dieser Text wurde on der Basis von aktuellen Dating from the Federal Institutes for Arzneimittel and Medizinprodukte (BfArM) generated. Datenupdates gibt es, sobald sich Neuigkeiten ergeben (due at 23.08.2024, 12:00 Uhr). In case of anmerkungen or rückfragen we contact a [email protected].+++ +++

roj/news.de